Key terms
About YTEN
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest YTEN news
Apr 03
7:46am ET
Hold Recommendation on Yield10 Bioscience Amid Commercialization and Capital Uncertainties
Apr 02
7:35am ET
Balancing Potential Growth with Financial Challenges: A Hold Rating for Yield10 Bioscience
Apr 01
4:03pm ET
Yield10 Bioscience reports Q4 EPS (27c), consensus (30c)
Mar 21
8:32am ET
Yield10 announces USDA-APHIS determined camelina can be grown, bred in U.S.
Feb 29
8:45am ET
Yield10 Bioscience reports on proprietary varieties of winter camilina
Feb 16
1:02pm ET
Yield10 Bioscience Granted Extension to Meet Nasdaq Criteria
Feb 14
11:42am ET
Yield10 Bioscience Licenses Trait Tech for Biofuel Boost
Feb 14
9:05am ET
Yield10 Bioscience grants global license to VISION Bioenergy Oilseeds
Feb 09
5:16am ET
Yield10 Bioscience Accelerates Omega-3 Camelina Launch
Feb 08
7:24am ET
Yield10 Bioscience downgraded to Hold from Buy at Lake Street
Feb 07
5:46pm ET
Yield10 Bioscience provides update on Omega-3 Camelina program
Jan 08
8:59am ET
Yield10 Bioscience files request for regulatory status review with USDA-APHIS
No recent press releases are available for YTEN
YTEN Financials
Key terms
Ad Feedback
YTEN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
YTEN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
